학술논문
Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, doubleblind, placebo-controlled trial.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2024, Vol. 20 Issue 1, p1-13, 13p
Subject
Language
ISSN
21645515